Skip to content
healthcare.dev

Alka-Seltzer Heartburn and Pain

NDC 0280-0160, ANHYDROUS CITRIC ACID, ASPIRIN, and SODIUM BICARBONATE, tablet, effervescent, from Bayer HealthCare LLC..

Product NDC
0280-0160
Status
Listed
Labeler
Bayer HealthCare LLC.
Dosage form
TABLET, EFFERVESCENT
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M013
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0280-0160 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ANHYDROUS CITRIC ACID1000 mg/1
  • ASPIRIN325 mg/1
  • SODIUM BICARBONATE1916 mg/1

Pharmacologic classes

Acidifying Activity [MoA]; Alkalinizing Activity [MoA]; Anti-Inflammatory Agents, Non-Steroidal [CS]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Cyclooxygenase Inhibitors [MoA]; Decreased Coagulation Factor Activity [PE]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]

Package NDCNDC-11Package
0280-0160-010028001600158 POUCH in 1 CARTON (0280-0160-01) / 2 TABLET, EFFERVESCENT in 1 POUCH
0280-0160-02002800160026 POUCH in 1 CARTON (0280-0160-02) / 2 TABLET, EFFERVESCENT in 1 POUCH
0280-0160-030028001600312 POUCH in 1 CARTON (0280-0160-03) / 2 TABLET, EFFERVESCENT in 1 POUCH
0280-0160-040028001600418 POUCH in 1 CARTON (0280-0160-04) / 2 TABLET, EFFERVESCENT in 1 POUCH
0280-0160-050028001600536 POUCH in 1 CARTON (0280-0160-05) / 2 TABLET, EFFERVESCENT in 1 POUCH

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0280-0160 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0280-0160 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0280-0160. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.